News

April 5, 2019April 5, 2019

Fertility Treatments Do Not Affect Child’s Risk for Developing Juvenile Idiopathic Arthritis, Large Study Finds

News

Children who were conceived by women using fertility treatments do not show an increased risk for juvenile idiopathic arthritis (JIA), a large Danish population study reports. The study, “Risk of ... Read more

April 2, 2019April 2, 2019

Treatment Failure, Adverse Reactions in JIA Patients Potentially Linked to Antibodies Against Biologic Agents, Study Suggests

News

Approximately 17% of juvenile idiopathic arthritis (JIA) patients treated with biologic agents develop anti-drug antibodies (ADAbs) that can be associated with treatment failure and adverse events, a review study shows. ... Read more

March 29, 2019March 29, 2019

Many JIA Patients Stop Methotrexate Monotherapy Treatment After 2 Years, Study Finds

News

More than half of juvenile idiopathic arthritis (JIA) patients treated with methotrexate monotherapy stop taking it for a variety of reasons two years after beginning treatment, and about a third experience one ... Read more

March 26, 2019March 26, 2019

Study: Young Women with JIA Have Low Prevalence of Sexual Dysfunction

News

Young women with juvenile idiopathic arthritis (JIA) have a low prevalence of sexual dysfunction problems, a study says. The findings of the study, “Sexual function in female juvenile idiopathic arthritis patients,” ... Read more

March 22, 2019March 22, 2019

Kineret Effective As Early First-Line Treatment for Systemic JIA, 5-Year Follow-up Study Shows

News

Kineret (anakinra) is able to rapidly halt disease activity and sustain long-term remission as an initial single treatment for patients with systemic juvenile idiopathic arthritis (sJIA), a five-year follow-up study says. ... Read more

March 19, 2019

Machine Learning Used to Identify Changes in Immune System in JIA Patients, Study Reports

News

Researchers have used machine learning to identify changes to the immune system associated with juvenile idiopathic arthritis (JIA). Understanding these changes may lead to better diagnosis and treatment options for ... Read more

March 12, 2019March 12, 2019

Mobile Technologies May Help JIA Patients Manage Health, Study Reports

News

Mobile health technologies may help people with juvenile idiopathic arthritis (JIA) keep track of their health status and communicate with their physicians, improving their ability to make informed decisions about ... Read more

March 8, 2019March 8, 2019

Spanish Survey Reveals Pediatricians’ Misconceptions About JIA

News

Approximately half of pediatricians and pediatric residents in Spain have wrong beliefs and misconceptions about the incidence and manifestation of juvenile idiopathic arthritis, a national survey showed. The findings were ... Read more

March 5, 2019March 5, 2019

Genentech’s Actemra Not Linked to Higher Risk of Infection in Children With sJIA or pcJIA, Trials Show

News

Genentech‘s Actemra (tocilizumab), a medicine approved for the treatment of certain types of juvenile idiopathic arthritis (JIA), is not linked to a higher risk of infections in children with systemic juvenile idiopathic ... Read more

February 27, 2019February 27, 2019

Tacrolimus May be Effective Therapeutic Option for Children With SOJIA, Small Study Says

News

Tacrolimus, an investigational immunosuppressive treatment, may be an effective therapeutic option for children and adolescents with systemic-onset juvenile idiopathic arthritis (SOJIA), a study says. The study, “Treatment of patients with ... Read more